GREG CLARY: Open Payments
NPI 1659317360 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 34 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $289 |
| Lilly USA, LLC | 4 | $76 |
| Astellas Pharma US Inc | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, MOUNJARO, VRAYLAR, Veozah, INGREZZA, JARDIANCE, ZEPBOUND, ACCRUFER.
Industry payments across NC — which companies pay providers there.
